Researchers have reported that the ability of gut bacteria to break down fat is disrupted in people with Parkinson’s, resulting in issues with the production of bile acid.
Researchers have published evidence that a class of drugs commonly used for the treatment of prostate enlargement may have beneficial properties for Parkinson’s.
Recent post-hoc analysis of the Steady-PD3 trial data has highlighted some interesting effects.
BNB and AskBio have joined forces to expand a gene therapy programme for Parkinson’s
There is increasing evidence that inflammation and the immune system might have contributory roles in the development and progression of Parkinson’s.